SCHEMBL10153503

SCHEMBL10153503

c1ccc(C(c2ccccc2)(c2cc3c4ccccc4n4c5ccncc5c(c2)c34)c2cc3c4ccccc4n4c5ccncc5c(c2)c34)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 4/20 0.44
MAOB P27338 4/20 0.44
ACHE P22303 3/20 0.44
CYP2D6 P10635 1/20 0.39
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
TOP2A P11388 1/20 0.35
ALDH1A1 P00352 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
SLC6A2 P23975 2/20 0.33
HDAC3 O15379 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
RAD52 P43351 1/20 0.32
FGFR1 P11362 1/20 0.31
CYP11B1 P15538 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10153918 0.86 MAOA (0.47) MAOAMAOBACHECYP2D6DDB1
SCHEMBL16656735 0.80 MAOA (0.56) MAOAMAOBACHECYP2D6DDB1
SCHEMBL10153562 0.80 MAOA (0.49) MAOAMAOBACHECYP2D6DDB1
SCHEMBL10153435 0.79 MAOA (0.46) MAOAMAOBACHECYP2D6DDB1
SCHEMBL17265102 0.78 MAOA (0.48) MAOAMAOBACHECYP2D6DDB1
SCHEMBL17265103 0.78 MAOA (0.48) MAOAMAOBACHECYP2D6DDB1
SCHEMBL10153489 0.77 MAOA (0.47) MAOAMAOBACHECYP2D6DDB1
SCHEMBL10153904 0.77 MAOA (0.47) MAOAMAOBACHECYP2D6DDB1
SCHEMBL16656736 0.76 MAOA (0.51) MAOAMAOBACHECYP2D6DDB1
SCHEMBL10153516 0.75 KDM4E (0.38) ALDH1A1KDM4EPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8421066-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2013-04-16 US disclosed
US-8421066-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2013-04-16 US disclosed
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-07-12 US disclosed
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-07-12 US disclosed
US-8174002-B2 Organic electroluminescence device FUJIFILM CORPORATION (JP) 2012-05-08 US disclosed
US-8174002-B2 Organic electroluminescence device FUJIFILM CORPORATION (JP) 2012-05-08 US disclosed
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 MAOA 1485/4885MAOB 1553/4885ACHE 1356/4885
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 MAOA 1485/4885MAOB 1553/4885ACHE 1356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.